167 related articles for article (PubMed ID: 33676699)
21. Tissue distribution of ³⁵S-labelled perfluorooctane sulfonate in adult mice after oral exposure to a low environmentally relevant dose or a high experimental dose.
Bogdanska J; Borg D; Sundström M; Bergström U; Halldin K; Abedi-Valugerdi M; Bergman A; Nelson B; Depierre J; Nobel S
Toxicology; 2011 Jun; 284(1-3):54-62. PubMed ID: 21459123
[TBL] [Abstract][Full Text] [Related]
22. Potential toxicity of environmentally relevant perfluorooctane sulfonate (PFOS) concentrations to yellow-legged gull Larus michahellis embryos.
Parolini M; Colombo G; Valsecchi S; Mazzoni M; Possenti CD; Caprioli M; Dalle-Donne I; Milzani A; Saino N; Rubolini D
Environ Sci Pollut Res Int; 2016 Jan; 23(1):426-37. PubMed ID: 26310703
[TBL] [Abstract][Full Text] [Related]
23. Effect of prenatal PFOS exposure on liver cell function in neonatal mice.
Liang X; Xie G; Wu X; Su M; Yang B
Environ Sci Pollut Res Int; 2019 Jun; 26(18):18240-18246. PubMed ID: 31041707
[TBL] [Abstract][Full Text] [Related]
24. Comparative Hepatotoxicity of a Novel Perfluoroalkyl Ether Sulfonic Acid, Nafion Byproduct 2 (H-PFMO2OSA), and Legacy Perfluorooctane Sulfonate (PFOS) in Adult Male Mice.
Wang Z; Yao J; Guo H; Sheng N; Guo Y; Dai J
Environ Sci Technol; 2022 Jul; 56(14):10183-10192. PubMed ID: 35786879
[TBL] [Abstract][Full Text] [Related]
25. Developmental toxicity and DNA damage to zebrafish induced by perfluorooctane sulfonate in the presence of ZnO nanoparticles.
Du J; Wang S; You H; Jiang R; Zhuang C; Zhang X
Environ Toxicol; 2016 Mar; 31(3):360-71. PubMed ID: 25258305
[TBL] [Abstract][Full Text] [Related]
26. Chronic perfluorooctane sulfonate (PFOS) exposure induces hepatic steatosis in zebrafish.
Cheng J; Lv S; Nie S; Liu J; Tong S; Kang N; Xiao Y; Dong Q; Huang C; Yang D
Aquat Toxicol; 2016 Jul; 176():45-52. PubMed ID: 27108203
[TBL] [Abstract][Full Text] [Related]
27. Perfluorooctane sulfonate (PFOS) disturbs fatty acid metabolism in Caenorhabditis elegans: Evidence from chemical analysis and molecular mechanism exploration.
Wei C; Zhou Z; Wang L; Huang Z; Liang Y; Zhang J
Chemosphere; 2021 Aug; 277():130359. PubMed ID: 34384190
[TBL] [Abstract][Full Text] [Related]
28. Transcriptome analysis of acute exposure of the Manila clam, Ruditapes philippinarum to perfluorooctane sulfonate (PFOS).
Zhang L; Sun W; Chen H; Tian F; Cai W
Comp Biochem Physiol C Toxicol Pharmacol; 2020 May; 231():108736. PubMed ID: 32142923
[TBL] [Abstract][Full Text] [Related]
29. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations.
Thibodeaux JR; Hanson RG; Rogers JM; Grey BE; Barbee BD; Richards JH; Butenhoff JL; Stevenson LA; Lau C
Toxicol Sci; 2003 Aug; 74(2):369-81. PubMed ID: 12773773
[TBL] [Abstract][Full Text] [Related]
30. Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone system.
Yu WG; Liu W; Jin YH; Liu XH; Wang FQ; Liu L; Nakayama SF
Environ Sci Technol; 2009 Nov; 43(21):8416-22. PubMed ID: 19924978
[TBL] [Abstract][Full Text] [Related]
31. Ultrasonic-induced tonic convulsion in rats after subchronic exposure to perfluorooctane sulfonate (PFOS).
Kawamoto K; Sato I; Tsuda S; Yoshida M; Yaegashi K; Saito N; Liu W; Jin Y
J Toxicol Sci; 2011 Jan; 36(1):55-62. PubMed ID: 21297341
[TBL] [Abstract][Full Text] [Related]
32. Induction of apoptosis and CYP4A1 expression in Sprague-Dawley rats exposed to low doses of perfluorooctane sulfonate.
Kim HS; Jun Kwack S; Sik Han E; Seok Kang T; Hee Kim S; Young Han S
J Toxicol Sci; 2011 Apr; 36(2):201-10. PubMed ID: 21467747
[TBL] [Abstract][Full Text] [Related]
33. Induction of p53-mediated apoptosis in splenocytes and thymocytes of C57BL/6 mice exposed to perfluorooctane sulfonate (PFOS).
Dong GH; Wang J; Zhang YH; Liu MM; Wang D; Zheng L; Jin YH
Toxicol Appl Pharmacol; 2012 Oct; 264(2):292-9. PubMed ID: 22959464
[TBL] [Abstract][Full Text] [Related]
34. In vivo immunotoxicity of perfluorooctane sulfonate in BALB/c mice: Identification of T-cell receptor and calcium-mediated signaling pathway disruption through gene expression profiling of the spleen.
Lv QY; Wan B; Guo LH; Yang Y; Ren XM; Zhang H
Chem Biol Interact; 2015 Oct; 240():84-93. PubMed ID: 26300304
[TBL] [Abstract][Full Text] [Related]
35. Apoptotic gene expression profiles and DNA damage levels in rat liver treated with perfluorooctane sulfonate and protective role of curcumin.
Eke D; Çelik A; Yilmaz MB; Aras N; Kocatürk Sel S; Alptekin D
Int J Biol Macromol; 2017 Nov; 104(Pt A):515-520. PubMed ID: 28634058
[TBL] [Abstract][Full Text] [Related]
36. Perfluorooctane Sulfonate-Induced Hepatic Steatosis in Male Sprague Dawley Rats Is Not Attenuated by Dietary Choline Supplementation.
Bagley BD; Chang SC; Ehresman DJ; Eveland A; Zitzow JD; Parker GA; Peters JM; Wallace KB; Butenhoff JL
Toxicol Sci; 2017 Dec; 160(2):284-298. PubMed ID: 28973659
[TBL] [Abstract][Full Text] [Related]
37. Hepatoprotective benefits of vitamin C against perfluorooctane sulfonate-induced liver damage in mice through suppressing inflammatory reaction and ER stress.
Su M; Liang X; Xu X; Wu X; Yang B
Environ Toxicol Pharmacol; 2019 Jan; 65():60-65. PubMed ID: 30551094
[TBL] [Abstract][Full Text] [Related]
38. Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice.
Bijland S; Rensen PC; Pieterman EJ; Maas AC; van der Hoorn JW; van Erk MJ; Havekes LM; Willems van Dijk K; Chang SC; Ehresman DJ; Butenhoff JL; Princen HM
Toxicol Sci; 2011 Sep; 123(1):290-303. PubMed ID: 21705711
[TBL] [Abstract][Full Text] [Related]
39. In utero exposure to perfluorooctanoate (PFOA) or perfluorooctane sulfonate (PFOS) did not increase body weight or intestinal tumorigenesis in multiple intestinal neoplasia (Min/+) mice.
Ngo HT; Hetland RB; Sabaredzovic A; Haug LS; Steffensen IL
Environ Res; 2014 Jul; 132():251-63. PubMed ID: 24834819
[TBL] [Abstract][Full Text] [Related]
40. Perfluorooctane sulfonate (PFOS) disrupts blood-testis barrier by down-regulating junction proteins via p38 MAPK/ATF2/MMP9 signaling pathway.
Qiu L; Qian Y; Liu Z; Wang C; Qu J; Wang X; Wang S
Toxicology; 2016 Dec; 373():1-12. PubMed ID: 27818224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
